CIC
XRAY icon

Carnegie Investment Counsel’s Dentsply Sirona XRAY Stock Holding History

Carnegie Investment Counsel’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,843
Closed -$238K – 509
2022
Q1 		$238K Buy
4,843
+390
+9% +$20.6K 0.01% 447
2021
Q4 		$248K Buy
+4,453
New +$245K 0.01% 455

Other funds holding XRAY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Carnegie Investment Counsel's XRAY Position: Q2 2022 in Review

Carnegie Investment Counsel sold out of Dentsply Sirona (XRAY) in Q2 2022, closing a stake of 4,843 shares — an estimated $238K sold.

Carnegie Investment Counsel first reported a position in XRAY in Q4 2021 and held it in 2 quarters. The position peaked at $248K in Q4 2021. 470 funds tracked by Wall St. Rank hold XRAY as of Q2 2022.

  • Carnegie Investment Counsel reported no remaining Dentsply Sirona position as of Q2 2022 after selling out during the quarter.
  • Carnegie Investment Counsel sold 4,843 Dentsply Sirona shares in Q2 2022, an estimated $238K.
  • Carnegie Investment Counsel first reported a position in Dentsply Sirona in Q4 2021 and held it in 2 quarters.
  • Carnegie Investment Counsel's Dentsply Sirona position peaked at $248K in Q4 2021.
  • 470 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2022.

Based on Carnegie Investment Counsel's 13F filing for Q2 2022, filed 13 Jul 2022.